Cargando…
Rituximab
Rituximab (Rituxan(®), MabThera(®), and Genentech/Roche) is a chimeric murine/human monoclonal IgG1k antibody directed against the CD20 antigen located at the surface of normal and malignant B lymphocytes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/978-88-470-...
Autor principal: | Tridente, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121599/ http://dx.doi.org/10.1007/978-88-470-5313-7_35 |
Ejemplares similares
-
Alemtuzumab
por: Tridente, Giuseppe
Publicado: (2013) -
Biomedicines as Adverse Event Inducers
por: Tridente, Giuseppe
Publicado: (2013) -
Systemic Syndromes with Biomedicines
por: Tridente, Giuseppe
Publicado: (2013) -
Treatment with rituximab in idiopathic membranous nephropathy
por: Fiorentino, Marco, et al.
Publicado: (2016) -
Rituximab, MS, and pregnancy
por: Smith, Jessica B., et al.
Publicado: (2020)